Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 120,863 | 166,728 | 51,704 | 81,309 | 28,451 |
| Marketable Securities | 66,712 | 126,146 | 63,191 | 84,475 | N/A |
| Receivables | 13,431 | 14,741 | 19,660 | 17,280 | 18,320 |
| Inventories | 19,981 | 20,744 | 20,533 | 21,473 | 20,825 |
| Other current assets | 228,406 | 42,963 | 0 | 0 | 0 |
| TOTAL | $454,264 | $375,883 | $158,215 | $208,815 | $72,066 |
| Non-Current Assets | |||||
| PPE Net | 19,275 | 22,775 | 24,187 | 25,652 | 28,034 |
| Investments And Advances | 25,701 | 0 | 0 | 0 | 0 |
| Intangibles | 0 | 0 | 107,717 | 118,851 | 134,306 |
| Other Non-Current Assets | 68,514 | 213,687 | 32,948 | 36,992 | 40,808 |
| TOTAL | $113,490 | $236,462 | $164,852 | $181,495 | $203,148 |
| Total Assets | $567,754 | $612,345 | $323,067 | $390,310 | $275,214 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 5,000 | 2,083 | 6,838 |
| Accounts payable and accrued liabilities | 5,407 | 5,049 | 9,236 | 7,914 | 10,602 |
| Accrued Expenses | 29,783 | 21,435 | 21,019 | 9,153 | 4,920 |
| Other current liabilities | 25,633 | 20,804 | N/A | N/A | N/A |
| TOTAL | $108,308 | $65,895 | $109,327 | $43,443 | $49,568 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 3,414 | 8,194 | 10,049 |
| Deferred Revenues | 41,995 | 13,801 | 15,219 | 14,436 | 15,482 |
| Other Non-Current Liabilities | 26,552 | 33,730 | 32,008 | 89,657 | 92,590 |
| TOTAL | $35,155 | $74,728 | $50,538 | $117,081 | $131,050 |
| Total Liabilities | $143,463 | $140,623 | $159,865 | $160,524 | $180,618 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 390,072 | 378,986 | 290,118 | 79,064 | 77,199 |
| Common Shares | 404 | 396 | 83 | 80 | 77 |
| Retained earnings | -1,260,547 | -1,185,651 | -1,000,752 | -926,096 | -735,998 |
| Other shareholders' equity | -1,959 | 758 | 309,055 | 309,794 | -907 |
| TOTAL | $424,291 | $471,722 | $163,202 | $229,786 | $94,596 |
| Total Liabilities And Equity | $567,754 | $612,345 | $323,067 | $390,310 | $275,214 |